Knowledge Distillery

The impact of the COVID‐19 pandemic on PD patients is yet to be determined.

The authors conducted a longitudinal case-control 18F-FDG-PET study in patients diagnosed with COVID-19-related encephalopathy.

The effects of the COVID‐19 pandemic on telemedical care have not been described on a national level. Thus, the authors investigated the medical…

This nationwide study assessed the impact of the pandemic on stroke hospitalisation rates, patient characteristics, and 30‐day case fatality rates.

Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and…

The aim of this retrospective, international multicenter study was to assess the association between abnormal findings on chest and brain imaging in…

The purpose of this review was to provide an overview on current knowledge of neurological symptoms and complications of COVID-19, and to suggest…

Studies suggest an increased risk of adverse outcomes among patients with acute ischemic stroke (AIS) and COVID-19.

The objective of this matched cohort study was to establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2 ,…

Most human monoclonal antibodies (mAbs) neutralizing SARS-CoV-2 recognize the spike (S) protein receptor-binding domain and block virus interactions…

SARS-CoV-2 has currently precipitated the COVID-19 global health crisis. The authors of this article developed a medium-throughput drug screening…

COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after SARS in 2003 and MERS since 2012.